---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285623274.md"
description: "Progyny shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 guidance. Also, the company issued Q2 EPS guidance above estimates."
datetime: "2026-05-07T21:20:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285623274.md)
  - [en](https://longbridge.com/en/news/285623274.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285623274.md)
---

# 

Progyny shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 guidance. Also, the company issued Q2 EPS guidance above estimates.

### Related Stocks

- [PGNY.US](https://longbridge.com/en/quote/PGNY.US.md)

## Related News & Research

- [Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report | PGNY Stock News](https://longbridge.com/en/news/283875551.md)
- [Progyny Earnings Call Signals Confident, Profitable Growth](https://longbridge.com/en/news/285787043.md)
- [Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | ANRO Stock News](https://longbridge.com/en/news/286247939.md)
- [Progyny, Inc. 1Q 2026: Revenue $328.5M, EPS $0.29— 10-Q Summary](https://longbridge.com/en/news/285728505.md)
- [Vaxart files preliminary proxy, urges support for board as Phase 2b COVID readout, $61M cash runway into Q2 2027](https://longbridge.com/en/news/286969427.md)